Player FM 앱으로 오프라인으로 전환하세요!
The Struggles of India’s Vaccine Giant
Manage episode 295765775 series 2502803
When the coronavirus hit, the Serum Institute of India, the world’s largest vaccine maker, seemed uniquely positioned to help. It struck a deal with AstraZeneca, promising a billion vaccine doses to low- and middle-income nations.
Earlier this year, a ban instituted by Prime Minister Narendra Modi put a stop to those plans.
What has that meant for the nations promised millions of doses?
Guest: Emily Schmall, a South Asia correspondent for The New York Times based in New Delhi.
Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter.
Background reading:
- The Serum Institute vowed to protect its country from the coronavirus and inoculate the world’s poor, but India’s crisis has pushed it past its limits.
- Big-power muscle flexing helps explain many of the world’s vaccine inequities, but there’s another problem: The manufacturing challenge is unprecedented.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
2007 에피소드
Manage episode 295765775 series 2502803
When the coronavirus hit, the Serum Institute of India, the world’s largest vaccine maker, seemed uniquely positioned to help. It struck a deal with AstraZeneca, promising a billion vaccine doses to low- and middle-income nations.
Earlier this year, a ban instituted by Prime Minister Narendra Modi put a stop to those plans.
What has that meant for the nations promised millions of doses?
Guest: Emily Schmall, a South Asia correspondent for The New York Times based in New Delhi.
Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter.
Background reading:
- The Serum Institute vowed to protect its country from the coronavirus and inoculate the world’s poor, but India’s crisis has pushed it past its limits.
- Big-power muscle flexing helps explain many of the world’s vaccine inequities, but there’s another problem: The manufacturing challenge is unprecedented.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
2007 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.